Lack of effect of antenatal glucocorticoid therapy in the fetal baboon on cerebral cortical glucose transporter proteins

Journal of Medical Primatology

Volumn 36, Issue 1, 2007, Pages 17-20

  Antonow Schlorke, Iwa ^a   Ebert, Martin ^a   Li, Cun ^b   Gschanes, Andrea ^c   Witte, Otto W ^a   McDonald, Thomas ^b   Nathanielsz, Peter W ^b   Schwab, Matthias ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^c CIS Services   (Austria)

Author keywords

Betamethasone; GLUT1; GLUT3; Immuno histochemistry; Primate

Indexed keywords

BETAMETHASONE; GLUCOCORTICOID; GLUCOSE; GLUCOSE TRANSPORTER 1; GLUCOSE TRANSPORTER 3;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BABOON; BLOOD BRAIN BARRIER; CONTROLLED STUDY; FEMALE; FETUS; FRONTAL CORTEX; GESTATIONAL AGE; GLUCOSE TRANSPORT; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; NEOCORTEX; NERVE CELL MEMBRANE; NONHUMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION;

ANIMALS; BETAMETHASONE; CEREBRAL CORTEX; FEMALE; FETUS; GENE EXPRESSION REGULATION; GLUCOCORTICOIDS; GLUCOSE TRANSPORTER TYPE 1; GLUCOSE TRANSPORTER TYPE 3; PAPIO CYNOCEPHALUS; PREGNANCY;

PAPIO; PRIMATES;

EID: 33846185391     PISSN: 00472565     EISSN: 16000684     Source Type: Journal    
DOI: 10.1111/j.1600-0684.2006.00210.x     Document Type: Article

References (20)

1. Antonow-Schlorke I, Schwab M, Li C, Nathanielsz PW: Glucocorticoid exposure at the dose used clinically alters cytoskeletal proteins and presynaptic terminals in the fetal baboon brain. J Physiol 2003; 547: 117-23.
2. Borski RJ: Nongenomic membrane actions of glucocorticoids in vertebrates. Trends Endocrinol Metab 2000; 11: 427-36.
3. Cornford EM, Hyman S, Swartz BE: The human brain GLUT1 glucose transporter: Ultrastructural localization to the blood-brain barrier endothelia. J Cereb Blood Flow Metab 1994; 14: 106-12.
4. Derks JB, Giussani DA, Jenkins SL, Wentworth RA, Visser GH, Padbury JF, Nathanielsz PW: A comparative study of cardiovascular, endocrine and behavioural effects of betamethasone and dexamethasone administration to fetal sheep. J Physiol Lond 1997; 499: 217-26.
5. Doyle P, Guillaume-Gentil C, Rohner-Jeanrenaud F, Jeanrenaud B: Effects of corticosterone administration on local cerebral glucose utilization of rats. Brain Res 1994; 645: 225-30.
6. Gschanes A, Boado R, Sametz W, Windisch M: The drug cerebrolysin and its peptide fraction E021 increase the abundance of the blood-brain barrier GLUT1 glucose transporter in brains of young and old rats. Histochem J 2000; 32: 71-7.
7. Hendrickx AG, Peterson PE: Perspectives on the use of the baboon in embryology and teratology research. Hum Reprod Update 1997; 3: 575-92.
8. Horner HC, Packan DR, Sapolsky RM: Glucocorticoids inhibit glucose transport in cultured hippocampal neurons and glia. Neuroendocrinology 1990; 52: 57-64.
9. Joels M, De Kloet ER: Control of neuronal excitability by corticosteroid hormones. Trends Neurosci 1992; 15: 25-30.
10. Joels M, De Kloet ER: Mineralocorticoid and glucocorticoid receptors in the brain. Implications for ion permeability and transmitter systems. Prog Neurobiol 1994; 43: 1-36.
11. Koenen SV, Mecenas CA, Smith GS, Jenkins S, Nathanielsz PW: Effects of maternal betamethasone administration on fetal and maternal blood pressure and heart rate in the baboon at 0.7 of gestation. Am J Obstet Gynecol 2002; 186: 812-7.
12. Maher F, Vannucci S, Takeda J, Simpson IA: Expression of mouse-GLUT3 and human-GLUT3 glucose transporter proteins in brain. Biochem Biophys Res Commun 1992; 182: 703-11.
13. Nualart F, Godoy A, Reinicke K: Expression of the hexose transporters GLUT1 and GLUT2 during the early development of the human brain. Brain Res 1999; 824: 97-104.
14. Pardridge WM, Boado RJ, Farrell CR: Brain-type glucose transporter (GLUT-1) is selectively localized to the blood-brain barrier. J Biol Chem 1990; 265: 18035-40.
15. Schleussner E, Arnscheidt C, Müller T, Schneider U, Haueisen J, Schwab K, Schwab M: Effects of antenatal glucocorticoids on human fetal cortical function detected by fetal magnetencephalography. J Soc Gynecol Invest 2004; 11 (Suppl.): 69.
16. Schwab M, Antonow-Schlorke I, Kühn B, Müller T, Schubert H, Walter B, Sliwka U, Nathanielsz PW: Effect of antenatal betamethasone treatment on microtubule associated proteins MAP1B and MAP2 in fetal sheep. J Physiol Lond 2001; 530: 497-506.
17. Schwab M, Rödel M, Schmidt K, Müller T, Schubert H, Anwar MA, Nathanielsz PW: Nonlinear changes of electrocortical activity after antenatal betamethasone treatment in fetal sheep. J Physiol Lond 2001; 531: 535-43.
18. Schwab M, Wichmann G, Maurer I, Loehle M, Nathanielsz PW, Witte OW: Antenatal glucocorticoids suppress mitochondrial activity but do not decrease ATP content in the fetal ovine brain. J Soc Gynecol Invest 2006; 13 (Suppl.): 732.
19. Tuor UI, Yager JY, Bascaramurty S, Delbigio MR: Dexamethasone prevents hypoxia/ischemia-induced reductions in cerebral glucose utilization and high-energy phosphate metabolites in immature brain. J Neurochem 1997; 69: 1954-63.
20. Vannucci SJ, Seaman LB, Brucklacher RM, Vannucci RC: Glucose transport in developing rat brain: Glucose transporter proteins, rate constants and cerebral glucose utilization. Mol Cell Biochem 1994; 140: 177-84.